Hello and welcome back to Equitya podcast about the business of startups, where we uncover the numbers and nuance behind the headlines.
This is what we started with:
- Short note from Becca on Neumann’s return and whether follow-up financing is an option for Flow – given the reactions of some investors.
- Our two deals of the week include an innovative step for hearing aid startups and a new take on international money transfer.
- For hearing loss technology, a new FDA ruling allows hearing aids to be sold without a prescription. We delved into how this regulatory change opens the door for startups to innovate in the category.
- Speaking of regulatory pain, we talked about how Startups With Employee Benefits Can Escape Cost Cuts because companies want to retain talent. I don’t know about you, but I’d rather lose free food over mental health support.
- We ended with comments on two geographic areas.
- Looking to the Midwest, we talked about how LPs aren’t supporting funds in the region this year, despite many VCs seeing it as one of the safer areas to invest right now.
- When we compared the Southeast and the Midwest, we talked about how lower valuations help both regions have a good year.
And that’s all for now. We’ll see you next week, and in the meantime, if you’re up for it, consider giving us a great rating on Apple Podcasts. It goes a long way.